Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
12 October 2013 - 7:46AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number
0-28298
ONYX
PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
249 East Grand Avenue
South San Francisco, CA 94080
Telephone: (650) 266-0000
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
4.00% Convertible Senior Notes due 2016
(Title of each class of securities covered by this Form)
None
(Titles of all
other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the
box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
Rule 12g-4(a)(1)
|
|
¨
|
Rule 12g-4(a)(2)
|
|
¨
|
Rule 12h-3(b)(1)(i)
|
|
x
|
Rule 12h-3(b)(1)(ii)
|
|
¨
|
Rule 15d-6
|
|
¨
|
Approximate number of holders of record as of the certification or notice date: 28
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, Onyx Pharmaceuticals, Inc. has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
Date: October 11, 2013
|
|
|
|
|
ONYX PHARMACEUTICALS, INC.
|
|
|
By:
|
|
/s/ David J. Scott
|
|
|
Name:
|
|
David J. Scott
|
|
|
Title:
|
|
Senior Vice President, General Counsel and Secretary
|
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From May 2024 to Jun 2024
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Onyx Pharmaceuticals, Inc. (MM) (NASDAQ): 0 recent articles
More Onyx Pharmaceuticals Inc News Articles